前收市價 | 0.6000 |
開市 | 0.1000 |
買盤 | 0.3500 |
賣出價 | 5.7000 |
拍板 | 515.00 |
到期日 | 2024-07-26 |
今日波幅 | 0.1000 - 1.7300 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 3 |
While CF remains the main area of focus, Vertex (VRTX) has seen rapid success in its non-CF pipeline candidates' development in the past year.
The biotech's shares have traded sideways for over a year, but better days could be on the near-term horizon.
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.